Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

FDA approves new AI-enabled wearable cardioverter defibrillator
The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.
PFA associated with elevated risk of heart damage, real-world data show
Patient outcomes do not appear to be negatively impacted by these risks, researchers noted. The new data were presented at Heart Rhythm 2025 and published in JACC: Clinical Electrophysiology.
Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients
New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.
PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data
Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies.
Medtronic receives FDA approval for smallest defibrillation lead of its kind
Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.

Jewel Patch Wearable Cardioverter Defibrillator from Element Science

FDA approves new AI-enabled wearable cardioverter defibrillator

The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.

PFA associated with elevated risk of heart damage, real-world data show

Patient outcomes do not appear to be negatively impacted by these risks, researchers noted. The new data were presented at Heart Rhythm 2025 and published in JACC: Clinical Electrophysiology.

doctor with overweight patient who may be treated with TAVR or surgery

Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients

New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.

Heart Rhythm 2025 Heart Rhythm Society President Kenneth A. Ellenbogen, MD

PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data

Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies.

OmniaSecure defibrillation lead for placement within a patient’s right ventricle

Medtronic receives FDA approval for smallest defibrillation lead of its kind

Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.

Alexander Kolomaya, MD, a cardiology resident at the University of Utah, presented a study on U.S. national trends in left atrial appendage occlusion (LAAO) volume and open payments from vendors to operators at the American Heart Association 2024 meeting.

Vendor payments not responsible for rising popularity of LAAO procedures

Consulting fees and other vendor payments do not appear to be directly influencing U.S. physicians to implant more Watchman devices. Researcher Alexander Kolomaya, MD, discussed his team's findings on this topic.

AI healthcare doctor surgery procedure artificial intelligence

AI helps cardiologists terminate AFib for good with ablation

Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care.

doctor patient discharge after heart surgery

Same-day discharge after cardiac ablation: Cardiologists share recommendations

Same-day discharge won't always be a great fit after cardiac ablation, of course, but it has been associated with considerable patient satisfaction as well as improved efficiency and substantial cost savings. The Heart Rhythm Society and American College of Cardiology have shared a new scientific statement on the subject.